⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 6 May, 2019    By - Dr Clemens
Cerebral Small Vessel, But Not Large Vessel Disease, Is Associated With Impaired Cerebral Autoregulation During Cardiopulmonary Bypass

AUTHORS: Nomura, Yohei, MD et al Anesthesia & Analgesia: December 2018 – Volume 127 – Issue 6 – p 1314–1322 BACKGROUND: Impaired cerebral blood flow (CBF) autoregulation during cardiopulmonary bypass (CPB) is associated with stroke and other adverse outcomes. Large and small arterial stenosis is prevalent in patients undergoing cardiac surgery. We hypothesize that large and/or […]

Read More
Uncategorized Published - 6 May, 2019    By - Dr Clemens
A Systematic Review Evaluating Neuraxial Morphine and Diamorphine-Associated Respiratory Depression After Cesarean Delivery

AUTHORS: Sharawi, Nadir, MBBS, FRCA, MSc et al Anesthesia & Analgesia: December 2018 – Volume 127 – Issue 6 – p 1385–1395 The prevalence of neuraxial opioid–induced clinically significant respiratory depression (CSRD) after cesarean delivery is unknown. We sought to review reported cases of author-reported respiratory depression (ARD) to calculate CSRD prevalence. A 6-database literature search […]

Read More
Uncategorized Published - 4 May, 2019    By - Dr Clemens
Dr. Reddy’s Laboratories Announces the Launch of Propofol Injectable Emulsion, USP in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Propofol Injectable Emulsion, USP, a therapeutic equivalent generic version of DIPRIVAN (propofol) Injectable Emulsion, USP, approved by the U.S. Food and Drug Administration (USFDA). Dr. Reddy’s is committed to providing […]

Read More
Uncategorized Published - 3 May, 2019    By - Dr Clemens
Cardiac Risk of Noncardiac Surgery After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents

AUTHORS: Smith, Bradford B., MD et al Anesthesia & Analgesia: April 2019 – Volume 128 – Issue 4 – p 621–628 BACKGROUND: Noncardiac surgery (NCS) following percutaneous coronary intervention (PCI) with stenting is sometimes associated with major adverse cardiac events (MACEs). Second-generation drug-eluting stents (DES) were developed to decrease the incidence of MACE seen with bare […]

Read More
Uncategorized Published - 3 May, 2019    By - Dr Clemens
Impact of Preoperative Erythropoietin on Allogeneic Blood Transfusions in Surgical Patients

AUTHORS: Cho, Brian C., MD et al Anesthesia & Analgesia: May 2019 – Volume 128 – Issue 5 – p 981–992 BACKGROUND: Erythropoietic-stimulating agents such as erythropoietin have been used as part of patient blood management programs to reduce or even avoid the use of allogeneic blood transfusions. We review the literature to evaluate the effect […]

Read More